Skip to Main Content

Paper Details

CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
Nat Med
73
2015
6q22, H3K4me2 histone, HOXB13, RFX6, SNPs, TALEN, TC, CC) , androgens, cell lines, differentially expressed genes, functional SNPs, homeobox B13, identifi, isogenic 22Rv1 prostate cancer cell lines, isogenic cell lines, non-, noncoding GWAS variants, noncoding sequence variants, prostate, prostate cancer, protein-coding genome, regulatory factor 6, regulatory factor 6 (RFX6) gene, rs339331, rs339331 region, single-nucleotide polymorphisms, transcription activator-like effector nuclease
Author NameAffiliation
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanNorris Comprehensive Cancer Center, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanNorris Comprehensive Cancer Center, University of Southern California
Younghun HanKeck School of Medicine, University of Southern California
Qiyuan LiDana-Farber Cancer Institute
Qiyuan LiMedical College, Xiamen University
Qiyuan LiCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Simon A GaytherKeck School of Medicine, University of Southern California
Simon A GaytherThe Eli and Edythe L. Broad Institute
J Keith JoungCenter for Computational and Integrative Biology, Massachusetts General Hospital
J Keith JoungCenter for Cancer Research, Massachusetts General Hospital
J Keith JoungMassachusetts General Hospital
J Keith JoungHarvard Medical School
J Keith JoungHarvard Medical School
Matthew L FreedmanDana-Farber Cancer Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanThe Eli and Edythe L. Broad Institute
Matthew L FreedmanDana-Farber Cancer Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanThe Eli and Edythe L. Broad Institute
  • 1 - 23

Datasets